Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...

The findings are particularly relevant as the T1D market continues to evolve. (Image Credits: Pexel) A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro ...

(Reuters) -Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday at the ...

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment, including conditions like NAION. Patients, such as James Norris and ...

There's a new S5 coming to Australia – no, not the Audi, but rather a new small, electric SUV from MG to take on BYD and Hyundai.

March 10 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and Mexico in the second half of ...

A WOMAN has shared how she regained her ''health and life'' after dropping 7st with Mounjaro. Numerous experts and NHS medics have warned about the dangers of fat jabs and say they shouldn't be ...